Clinical Immunogenicity Evaluation of Eptinezumab, a Therapeutic Humanized Monoclonal Antibody Targeting Calcitonin Gene-Related Peptide (CGRP) for the Preventive Treatment of Migraine

BACKGROUND: Eptinezumab is a humanized monoclonal antibody that selectively binds calcitonin gene-related peptide and is indicated for the preventive treatment of migraine in adults. This analysis characterizes the immunogenic profile of eptinezumab using data from clinical trials of eptinezumab for...

Descripción completa

Detalles Bibliográficos
Autores principales: Pederson, Susan, Biondi, David M., Allan, Brent, Cady, Roger, Schaeffler, Barbara, Baker, Brian, Latham, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573262/
https://www.ncbi.nlm.nih.gov/pubmed/34759933
http://dx.doi.org/10.3389/fimmu.2021.765822

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573262/
https://www.ncbi.nlm.nih.gov/pubmed/34759933
http://dx.doi.org/10.3389/fimmu.2021.765822

Ejemplares similares